INNV - Matinas BioPharma Dynavax top weekly healthcare gainers; InnovAge BeyondSpring trail

Posting the third consecutive weekly loss, the healthcare stocks in the S&P 500 fell ~0.4% over the week. While healthcare became the fourth worst performing sector, the broader index edged ~0.5% higher during the week. Among healthcare stocks with more than $300M market cap and over 100K average daily volume over the past five sessions, Matinas BioPharma (NYSE:MTNB) led the gainers. With a weekly rise of ~37.3%, the stock rode on the back of new data from Gilead (NASDAQ:GILD) for the oral form of COVID-19 antiviral remdesivir. Martinas (MTNB) has a collaboration with the National Institute of Allergy and Infectious Diseases ("NIAID") for oral remdesivir. Seeking Alpha contributor, Avisol Capital Partners argues why the stock will look even more compelling even as the recent surge in shares wanes. Dynavax Technologies (NASDAQ:DVAX) became the second-best performer with a gain of ~33.2%, thanks to positive data from partner Clover Biopharmaceuticals for its COVID-19 vaccine candidate, SCB-2019 which uses Dynavax's

For further details see:

Matinas BioPharma, Dynavax top weekly healthcare gainers; InnovAge, BeyondSpring trail